Abiomed Inc Revenue Growth Rates (ABMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Abiomed Inc   (NASDAQ: ABMD)
 

ABMD's Revenue Growth by Quarter and Year

Abiomed Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABMD Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter March -
3rd Quarter December -
2nd Quarter September 265.92
1st Quarter June 277.15
FY 543.07

ABMDs Annual Revenue
Abiomed Inc 's Revenue in the fiscal year 2022 $ 1,031.75 millions
Abiomed Inc 's Revenue in the fiscal year 2021 $ 847.52 millions
Abiomed Inc 's Revenue in the fiscal year 2020 $ 840.88 millions
Abiomed Inc 's Revenue in the fiscal year 2019 $ 769.43 millions
Abiomed Inc 's Revenue in the fiscal year 2018 $ 593.75 millions




ABMD Revenue second quarter 2023 Y/Y Growth Comment
Abiomed Inc reported Revenue growth of 7.17% year on year in the second quarter 2023, to $ 265.92 millions, this is lower than Abiomed Inc 's recent average Revenue improvement of 26.05%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 115 other companies have achieved higher Revenue growth. While Abiomed Inc ' s Revenue increase of 7.17% ranks overall at the positon no. 2516 in the second quarter 2023.


ABMD Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter March - 11.85 % 16.74 % -0.2 %
3rd Quarter December - 12.74 % 4.55 % 10.48 %
2nd Quarter September 7.17 % 18.3 % 2.34 % 12.76 %
1st Quarter June 9.72 % 53.22 % -20.62 % 15.37 %
FY   - 21.74 % 0.79 % -

Financial Statements
Abiomed Inc 's second quarter 2023 Revenue $ 265.92 millions ABMD's Income Statement
Abiomed Inc 's second quarter 2022 Revenue $ 248.14 millions Quarterly ABMD's Income Statement


ABMD Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter March - 3.32 % 4.14 % -6.73 %
3rd Quarter December - 5.26 % 10.44 % 8.1 %
2nd Quarter September -4.05 % -1.76 % 27.24 % -1.3 %
1st Quarter June 2.71 % 4.7 % -20.23 % 0.28 %
FY (Year on Year)   - 21.74 % 0.79 % -


Back to ABMD Growth rate Comparisons >> Back to ABMD Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #356
Overall #2516

Revenue Y/Y Growth Statistics
High Average Low
136.52 % 26.05 % -20.62 %
(Jun 30 2021)   (Jun 30 2020)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #356
Overall #2516
Revenue Y/Y Growth Statistics
High Average Low
136.52 % 26.05 % -20.62 %
(Jun 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Abiomed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
27.25 % 2.6 % -100 %
(Sep 30 2020)  


ABMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Abiomed Inc disclosed fall in Revenue from the first quarter by -4.05% to $ 265.92 millions, from $ 277.15 millions achived in the previous reporting period.

But that's not important problem, as Abiomed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 142 other companies have achieved higher Revenue quarter on quarter growth. While Abiomed Inc 's Revenue growth quarter on quarter, overall rank is 3133.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #143
Healthcare Sector #474
Overall #3133
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #143
Healthcare Sector #474
Overall #3133
Revenue Q/Q Growth Statistics
High Average Low
27.25 % 2.6 % -100 %
(Sep 30 2020)  


ABMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Abiomed Inc disclosed fall in Revenue from the first quarter by -4.05% to $ 265.92 millions, from $ 277.15 millions achived in the previous reporting period.

But that's not important problem, as Abiomed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 142 other companies have achieved higher Revenue quarter on quarter growth. While Abiomed Inc 's Revenue growth quarter on quarter, overall rank is 3133.


Abiomed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 1,074.10 $ 1,056.32 $ 1,031.75 $ 1,003.15 $ 973.64
Y / Y Revenue Growth (TTM) 10.32 % 12.94 % 21.74 % 23.4 % 21.27 %
Year on Year Revenue Growth Overall Ranking # 1330 # 1093 # 1386 # 100 # 1352
Seqeuential Revenue Change (TTM) 1.68 % 2.38 % 2.85 % 3.03 % 4.1 %
Seq. Revenue Growth (TTM) Overall Ranking # 2516 # 1195 # 1760 # 168 # 1822


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Abiomed Inc 's cumulative twelve months Revenue were $ 1,074 millions, company would post below average annual Revenue growth of 4.1% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Abiomed Inc 's Revenue growth from the 277.15% growth in Jun 30 2022.

In the Healthcare sector 208 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1093 to 1330.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 209
Overall # 1330

Revenue TTM Y/Y Growth Statistics
High Average Low
43.09 %
 24.04 %
-3.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 332
S&P 500 # 2516
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Abiomed Inc 's cumulative twelve months Revenue were $ 1,074 millions, company would post below average annual Revenue growth of -3.37% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Abiomed Inc 's Revenue growth from the 277.15% growth in Jun 30 2022.

In the Healthcare sector 208 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1093 to 1330.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 209
Overall # 1330

Revenue TTM Y/Y Growth Statistics
High Average Low
43.09 %
24.04 %
-3.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 332
S&P 500 # 2516




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ABMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Clearpoint Neuro Inc 12.51%$ 12.505 millions
Cerus Corporation12.44%$ 12.436 millions
Penumbra Inc12.39%$ 12.393 millions
Airsculpt Technologies Inc 12.24%$ 12.239 millions
Jazz Pharmaceuticals Plc12.23%$ 12.234 millions
Msa Safety Inc12.11%$ 12.110 millions
Cyclo Therapeutics Inc 11.95%$ 11.945 millions
Alimera Sciences Inc11.89%$ 11.890 millions
Sanuwave Health Inc 11.84%$ 11.839 millions
Vericel Corporation11.72%$ 11.723 millions
Provention Bio Inc 11.50%$ 11.504 millions
Nuwellis Inc 11.44%$ 11.441 millions
Talkspace Inc 11.28%$ 11.279 millions
Rockwell Medical inc 11.19%$ 11.190 millions
Ultragenyx Pharmaceutical Inc 11.09%$ 11.092 millions
Pro dex Inc 11.00%$ 11.003 millions
Addus Homecare Corp11.00%$ 11.000 millions
Intuitive Surgical Inc 10.98%$ 10.981 millions
Surgery Partners Inc 10.98%$ 10.980 millions
Pacific Health Care Organization Inc10.94%$ 10.940 millions
Globus Medical Inc 10.63%$ 10.633 millions
Conmed Corporation10.55%$ 10.554 millions
Eyepoint Inc 10.52%$ 10.520 millions
Charles River Laboratories International inc 10.40%$ 10.405 millions
Sotera Health Company9.97%$ 9.966 millions
Avanos Medical Inc 9.78%$ 9.777 millions
Cutera Inc 9.45%$ 9.452 millions
Novo Nordisk A9.20%$ 9.198 millions
Nuvasive Inc9.03%$ 9.025 millions
Vaso Corporation8.71%$ 8.715 millions


About Abiomed Inc Revenue Growth Rates (ABMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Abiomed Inc (CIK 815094).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-22-021880
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Abiomed Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.